PLIAGLIS

Product NDC
51672-5305
11-digit product format
516725305
Labeler code
51672
Product ID
51672-5305_0e6c04f1-804f-4d51-bdfd-bc21a0caeeb6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lidocaine and Tetracaine
Dosage form
CREAM
Route
TOPICAL
Labeler
Taro Pharmaceuticals U.S.A., Inc.
Application
NDA021717
Marketing category
NDA
Marketing start
2018-12-11
Marketing end
0000-00-00
Substance
LIDOCAINE; TETRACAINE
Active strength
70 mg/g; mg/g
Pharmacologic classes
Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Esters [CS],Local Anesthesia [PE],Ester Local Anesthetic [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
51672-5305-2GM - Gram51672-530575db73c3-f3a6-4519-8b58-7e47eeb985f412018-04-19

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51672-5305-2516725305021 TUBE in 1 CARTON (51672-5305-2) > 30 g in 1 TUBE1 tube2018-12-110000-00-00NoNoCurrent